{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:44:39Z","timestamp":1790019879027,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jns.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T22:58:26Z","timestamp":1538607506000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA"],"prefix":"10.1016","volume":"395","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-265X","authenticated-orcid":false,"given":"Maria","family":"Tsipi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-8896","authenticated-orcid":false,"given":"Myrto","family":"Poulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Fylaktou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Kosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0149-4642","authenticated-orcid":false,"given":"Eirini","family":"Tsoutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Roser","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Kokkinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kitsiou-Tzeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Fryssira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tzetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jns.2018.10.006_bb0015","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","article-title":"Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848","volume":"102","author":"Koczkowska","year":"2018","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17530059.2010.494660","article-title":"Neurofibromatosis type 1: diagnosis and recent advances","volume":"4","author":"Upadhyaya","year":"2010","journal-title":"Expert Opin. Med. Diagn."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0035","first-page":"575","article-title":"National institutes of health consensus development conference","volume":"45","author":"Neurofibromatosis. Conference statement","year":"1988","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cge.12625","article-title":"Neurofibromatosis type 1 and malignancy in childhood","volume":"89","author":"Varan","year":"2016","journal-title":"Clin. Genet."},{"issue":"4965","key":"10.1016\/j.jns.2018.10.006_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jns.2018.10.006_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/exd.13212","article-title":"Neurofibromatosis type 1 (NF1) gene: beyond cafe au lait spots and dermal neurofibromas","volume":"26","author":"Peltonen","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(91)90017-9","article-title":"cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product","volume":"11","author":"Marchuk","year":"1991","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"6327","key":"10.1016\/j.jns.2018.10.006_bb0080","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/351576a0","article-title":"Differential regulation of rasGAP and neurofibromatosis gene product activities","volume":"351","author":"Bollag","year":"1991","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.jns.2018.10.006_bb0085","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited - from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.jns.2018.10.006_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrc1653","article-title":"Neurofibromatosis type 1 - a model for nervous system tumour formation?","volume":"5","author":"Rubin","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jns.2018.10.006_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcdb.2016.02.007","article-title":"Neurofibromatosis type 1: fundamental insights into cell signalling and cancer","volume":"52","author":"Rad","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0100","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jns.2018.10.006_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum. Mutat."},{"issue":"11","key":"10.1016\/j.jns.2018.10.006_bb0110","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jns.2018.10.006_bb0115","first-page":"7(12)","article-title":"Hybridization capture-based next-generation sequencing to evaluate coding sequence and deep intronic mutations in the NF1 gene","author":"Cunha","year":"2016","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/humu.20246","article-title":"Expression of NF1 pseudogenes","volume":"26","author":"Yu","year":"2005","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a double-hit model for the NF1 gene in benign neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging genotype-phenotype relationships in patients with large NF1 deletions","volume":"136","author":"Kehrer-Sawatzki","year":"2017","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cge.12632","article-title":"Growth in neurofibromatosis 1 microdeletion patients","volume":"89","author":"Ning","year":"2016","journal-title":"Clin. Genet."},{"issue":"6","key":"10.1016\/j.jns.2018.10.006_bb0140","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0145","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/374821","article-title":"Elevated risk for MPNST in NF1 microdeletion patients","volume":"72","author":"De Raedt","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.12498","article-title":"The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features","volume":"87","author":"Ruggieri","year":"2015","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/j.jns.2018.10.006_bb0155","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.jns.2018.10.006_bb0175","series-title":"Modern Approaches To Quality Control","article-title":"Analysis of MLPA data using novel software coffalyser.NET by MRC-Holland","author":"Jordy Coffa","year":"2011"},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","article-title":"InterVar: clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP guidelines","volume":"100","author":"Li","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.jns.2018.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0195","doi-asserted-by":"crossref","first-page":"7.20.1","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"76","author":"Adzhubei","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"14","key":"10.1016\/j.jns.2018.10.006_bb0200","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/bioinformatics\/bti486","article-title":"PMUT: a web-based tool for the annotation of pathological mutations on proteins","volume":"21","author":"Ferrer-Costa","year":"2005","journal-title":"Bioinformatics"},{"issue":"17","key":"10.1016\/j.jns.2018.10.006_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.jns.2018.10.006_bb0210","doi-asserted-by":"crossref","first-page":"R232","DOI":"10.1186\/gb-2007-8-11-r232","article-title":"Determinants of protein function revealed by combinatorial entropy optimization","volume":"8","author":"Reva","year":"2007","journal-title":"Genome Biol."},{"issue":"16","key":"10.1016\/j.jns.2018.10.006_bb0215","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.jns.2018.10.006_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0225","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.jns.2018.10.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"7571","key":"10.1016\/j.jns.2018.10.006_bb0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"issue":"7571","key":"10.1016\/j.jns.2018.10.006_bb0240","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature15394","article-title":"An integrated map of structural variation in 2,504 human genomes","volume":"526","author":"Sudmant","year":"2015","journal-title":"Nature"},{"issue":"7616","key":"10.1016\/j.jns.2018.10.006_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0250","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ahg.12026","article-title":"Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients","volume":"77","author":"Nemethova","year":"2013","journal-title":"Ann. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0255","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12031-014-0286-7","article-title":"Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene","volume":"53","author":"Balla","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0260","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ejhg.2014.145","article-title":"Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?","volume":"23","author":"Pasmant","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmg.2016.11.001","article-title":"Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM platform","volume":"60","author":"Cali","year":"2017","journal-title":"Eur. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/bjmg-2017-0008","article-title":"Genetic analyses of the NF1 gene in Turkish neurofibromatosis type I patients and definition of three novel variants","volume":"20","author":"Ulusal","year":"2017","journal-title":"Balkan J Med Genet"},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0275","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cge.12177","article-title":"Neurofibromatosis type 1 in two siblings due to maternal germline mosaicism","volume":"85","author":"Trevisson","year":"2014","journal-title":"Clin. Genet."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0280","first-page":"1044","article-title":"Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism","volume":"57","author":"Lazaro","year":"1995","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0285","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/humrep\/des014","article-title":"Gonosomal mosaicism for an NF1 deletion in a sperm donor: evidence of the need for coordinated, long-term communication of health information among relevant parties","volume":"27","author":"Callum","year":"2012","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.0022-202X.2005.23834.x","article-title":"Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1","volume":"125","author":"Consoli","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0295","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/cge.12600","article-title":"Clinical presentations of 23 half-siblings from a mosaic neurofibromatosis type 1 sperm donor","volume":"89","author":"Ejerskov","year":"2016","journal-title":"Clin. Genet."},{"issue":"24","key":"10.1016\/j.jns.2018.10.006_bb0300","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1212\/WNL.0000000000003435","article-title":"Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1","volume":"87","author":"Payne","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0305","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.jns.2018.10.006_bb0310","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.jns.2018.10.006_bb0315","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.jns.2018.10.006_bb0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant","year":"2009","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.jns.2018.10.006_bb0325","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/onc.2013.587","article-title":"SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia","volume":"34","author":"Pasmant","year":"2015","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jns.2018.10.006_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2302\/kjm.2013-0002-RE","article-title":"Legius syndrome, an Update. Molecular pathology of mutations in SPRED1","volume":"62","author":"Brems","year":"2013","journal-title":"Keio J. Med."},{"issue":"7","key":"10.1016\/j.jns.2018.10.006_bb0335","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1074\/jbc.M115.703710","article-title":"Interaction between a domain of the negative regulator of the Ras-ERK pathway, SPRED1 protein, and the GTPase-activating protein-related domain of neurofibromin is implicated in legius syndrome and neurofibromatosis type 1","volume":"291","author":"Hirata","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jns.2018.10.006_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","article-title":"Molecular diagnosis of neurofibromatosis type 1: 2 years experience","volume":"6","author":"Griffiths","year":"2007","journal-title":"Familial Cancer"},{"issue":"9","key":"10.1016\/j.jns.2018.10.006_bb0345","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1002\/humu.20826","article-title":"Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations","volume":"29","author":"Pros","year":"2008","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.jns.2018.10.006_bb0350","first-page":"160","article-title":"An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age","volume":"77","author":"McKeever","year":"2008","journal-title":"Ulster Med. J."},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0355","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0036-1579766","article-title":"Neurofibromatosis: a review of NF1, NF2, and schwannomatosis","volume":"5","author":"Kresak","year":"2016","journal-title":"J. Pediatr. Genet."},{"issue":"2","key":"10.1016\/j.jns.2018.10.006_bb0360","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/01677063.2018.1456538","article-title":"Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes","volume":"32","author":"Sharafi","year":"2018","journal-title":"J. Neurogenet."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18304155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:29:58Z","timestamp":1541204998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18304155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":72,"alternative-id":["S0022510X18304155"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.006","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}